Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tiziana Life Sciences Ltd - Common Shares
(NQ:
TLSA
)
0.6815
-0.0935 (-12.06%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tiziana Life Sciences Ltd - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
December 17, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
December 04, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Elon Musk Says Amazon Founder Jeff Bezos Urged Tesla, SpaceX Investors To Dump Stakes, Predicting Trump's Loss
November 21, 2024
Tesla Inc (NASDAQ: TLSA) and SpaceX, chief executive officer, Elon Musk sparked a new controversy by saying that Jeff Bezos, the founder and executive chairman of Amazon.com, predicted President-elect...
Via
Benzinga
Topics
Government
Exposures
Political
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
November 19, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Cathie Wood Redirects Elon Musk's DOGE Focus Toward Nuclear Energy Amid Regulatory Challenges: Here's How Oklo, Cameco, Centrus Energy And Other Stocks Performed
November 18, 2024
Nuclear energy stocks and ETFs have come to the fore as ARK Invest's founder Cathie Wood reshared the firm's study on how regulatory hurdles and anti-nuclear sentiment have caused cost overruns and...
Via
Benzinga
Topics
ETFs
Energy
Exposures
Fossil Fuels
Donald Trump Gives Tesla Wings For 27% Rally Since Presidential Election
November 11, 2024
The EV giant received a substantial price target hike Monday, suggesting 24% upside.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
Tesla Reclaims $1 Trillion Market Cap For First Time Since 2022 In Huge Trump Run
November 08, 2024
Tesla stock is on pace for its best weekly performance since January 2023.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
Tesla Surges To 15-Month High On Election; Musk-Trump Alliance In Focus
November 06, 2024
Tesla stock is set to hit a 15-month high.
Via
Investor's Business Daily
Cathie Wood Sells Tesla Before Election; Musk Cabinet Position "Not What Shareholders Want To See"
November 05, 2024
Tesla stock flashed a sell signal Monday and is well below a traditional buy point.
Via
Investor's Business Daily
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
November 01, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
October 30, 2024
Includes initial funding of approximately $5 million, as well as the option for additional proceeds of approximately $5 million
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
October 30, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 18, 2024
Via
Benzinga
Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building
October 10, 2024
Consumer support for robotaxis is low for people who have not been inside a self-driving vehicle or live in a city where the vehicles operate.
Via
Benzinga
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
September 19, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Appoints New Chief Executive Officer
August 19, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
August 14, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
The 3 Best EV Stocks to Buy in August 2024
August 10, 2024
The best EV stocks may face an uphill battle, but their share prices seem too depressed after the latest plunge.
Via
InvestorPlace
Tiziana Life Sciences Granted FDA Fast Track Designation
July 24, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Receives $3.4 Million in Non-Dilutive Funding
June 28, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
June 28, 2024
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
Via
News Direct
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
June 26, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
June 17, 2024
Via
Benzinga
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
June 11, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
June 11, 2024
EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
June 07, 2024
Via
Benzinga
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
June 06, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
June 11, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
June 04, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
May 30, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.